ELAPRASE Concentrate for solution for infusion Ref.[9221] Active ingredients: Idursulfase

Source: European Medicines Agency (EU)  Revision Year: 2019  Publisher: Shire Human Genetic Therapies AB, Vasagatan 7, 111 20, Stockholm, Sweden

Product name and form

Elaprase 2 mg/ml concentrate for solution for infusion.

Pharmaceutical Form

Concentrate for solution for infusion (sterile concentrate).

A clear to slightly opalescent, colourless solution.

Qualitative and quantitative composition

Each vial contains 6 mg of idursulfase. Each ml contains 2 mg of idursulfase*.

Excipient with known effect: Each vial contains 0.482 mmol of sodium.

For the full list of excipients, see section 6.1.

* idursulfase is produced by recombinant DNA technology in a continuous human cell line.

Active Ingredient Description
Idursulfase

Idursulfase (idursulfase) is a purified form of the lysosomal enzyme iduronate-2-sulfatase, produced in a human cell line providing a human glycosylation profile, which is analogous to the naturally occurring enzyme. Elaprase is indicated for the long-term treatment of patients with Hunter syndrome (Mucopolysaccharidosis II, MPS II).

List of Excipients

Polysorbate 20
Sodium chloride
Dibasic sodium phosphate heptahydrate
Monobasic sodium phosphate monohydrate
Water for injections

Pack sizes and marketing

5 ml vial (type I glass) with a stopper (fluoro-resin coated butyl rubber), one piece seal and blue flipoff cap. Each vial contains 3 ml of concentrate for solution for infusion.

Pack sizes of 1, 4 and 10 vials. Not all pack sizes may be marketed.

Marketing authorization holder

Shire Human Genetic Therapies AB, Vasagatan 7, 111 20, Stockholm, Sweden

Marketing authorization dates and numbers

EU/1/06/365/001-003

Date of first authorisation: 08 January 2007

Date of latest renewal: 09 September 2016

Drugs

Drug Countries
ELAPRASE Austria, Brazil, Canada, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Japan, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey, United Kingdom, United States, South Africa

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.